Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2011-10-14 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: DAINVILLE (62000), Pas-de-Calais
SELARL PHARMACIE LAINE : revenue, balance sheet and financial ratios
SELARL PHARMACIE LAINE is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in DAINVILLE (62000),
this company of category PME
shows in 2022 a revenue of 1.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE LAINE (SIREN 535310973)
Indicator
2025
2024
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
1 670 696 €
1 556 806 €
1 389 730 €
1 503 977 €
1 408 628 €
1 537 182 €
1 500 845 €
Net income
53 003 €
43 318 €
72 918 €
66 172 €
34 904 €
60 047 €
47 392 €
84 236 €
81 722 €
EBITDA
N/C
N/C
101 623 €
102 028 €
52 887 €
92 648 €
68 960 €
122 917 €
127 541 €
Net margin
N/C
N/C
4.4%
4.3%
2.5%
4.0%
3.4%
5.5%
5.4%
Revenue and income statement
In 2025, SELARL PHARMACIE LAINE generates positive net income of 53 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 82 k€ -> 53 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
53 003 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 84%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
84.196%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.521%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE LAINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2024
2025
Debt ratio
385.322
287.357
237.975
195.252
295.957
156.741
131.639
96.319
84.196
Financial autonomy
18.53
22.909
26.584
30.445
23.13
34.764
38.514
45.46
48.521
Repayment capacity
16.751
17.274
30.123
18.585
51.61
14.535
12.413
None
None
Cash flow / Revenue
5.215%
4.594%
2.647%
3.682%
2.339%
4.385%
4.481%
None%
None%
Sector positioning
Debt ratio
84.22025
2022
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average
In 2025, the debt ratio of SELARL PHARMACIE LAINE (84.20) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.52%2025
2022
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average+5 pts over 3 years
In 2025, the financial autonomy of SELARL PHARMACIE LAINE (48.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
12.41 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELARL PHARMACIE LAINE (12.41) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 115.70. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
115.7
Liquidity indicators evolution SELARL PHARMACIE LAINE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2024
2025
Liquidity ratio
132.921
122.431
125.025
98.925
456.957
154.627
151.395
115.144
115.7
Interest coverage
18.844
20.869
33.431
21.979
33.664
10.206
8.186
None
None
Sector positioning
Liquidity ratio
115.72025
2022
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch-6 pts over 3 years
In 2025, the liquidity ratio of SELARL PHARMACIE LAINE (115.70) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
8.19x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of SELARL PHARMACIE LAINE (8.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE LAINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2024
2025
Operating WCR
153 326 €
143 450 €
165 021 €
143 540 €
146 491 €
109 630 €
142 861 €
0 €
0 €
Inventory turnover (days)
37
36
37
34
40
33
33
0
0
Customer payment term (days)
5
5
6
6
2
3
5
0
0
Supplier payment term (days)
41
43
44
41
52
38
41
0
0
Positioning of SELARL PHARMACIE LAINE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE LAINE is estimated at
841 958 €
(range 571 357€ - 1 321 149€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
571k€841k€1321k€
841 958 €Range: 571 357€ - 1 321 149€
NAF 5 année 2025
Valuation method used
Net Income Multiple
53 003 €
×
15.9x
=841 959 €
Range: 571 357€ - 1 321 150€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE LAINE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE LAINE
What is the revenue of SELARL PHARMACIE LAINE ?
The revenue of SELARL PHARMACIE LAINE in 2022 is 1.7 M€.
Is SELARL PHARMACIE LAINE profitable?
Yes, SELARL PHARMACIE LAINE generated a net profit of 53 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE LAINE ?
The headquarters of SELARL PHARMACIE LAINE is located in DAINVILLE (62000), in the department Pas-de-Calais.
Where to find the tax return of SELARL PHARMACIE LAINE ?
The tax return of SELARL PHARMACIE LAINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE LAINE operate?
SELARL PHARMACIE LAINE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart